99-70. Food Additive Petition Expedited ReviewGuidance for Industry and Center for Food Safety and Applied Nutrition Staff; Availability  

  • [Federal Register Volume 64, Number 2 (Tuesday, January 5, 1999)]
    [Notices]
    [Pages 517-518]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 99-70]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    [Docket No. 98D-1164]
    
    
    Food Additive Petition Expedited Review--Guidance for Industry 
    and Center for Food Safety and Applied Nutrition Staff; Availability
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food And Drug Administration (FDA) is announcing the 
    availability of a guidance document entitled ``Food Additive Petition 
    Expedited Review--Guidance for Industry and Center for Food Safety and 
    Applied Nutrition Staff.'' FDA believes it is in the interest of 
    enhanced food safety to review petitions for certain food additives in 
    an expedited manner. Expedited review will be considered when an 
    additive is intended to decrease incidences of foodborne illnesses 
    through its antimicrobial actions against human pathogens that might be 
    present in food.
    
    DATES: Written comments concerning this guidance may be submitted at 
    any time.
    
    ADDRESSES: Written comments concerning this guidance may be submitted 
    to the Dockets Management Branch (HFA-305), Food and Drug 
    Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. 
    Comments should be identified with the docket number found in brackets 
    in the heading of this document. Submit written requests for single 
    copies of the guidance to the Office of Premarket Approval (HFS-200), 
    Food and Drug Administration, 200 C St. SW., Washington DC 20204, or by 
    telephone to the Office of Premarket Approval at 202-418-3100 (voice), 
    or FAX 202-418-3131. All requests should identify the guidance by its 
    title of ``Food Additive Petition Expedited Review--Guidance for 
    Industry and Center for Food Safety and Applied Nutrition Staff.'' See 
    the Supplementary Information section for electronic access to the 
    guidance.
    
    FOR FURTHER INFORMATION CONTACT: Robert L. Martin, Center for Food 
    Safety and Applied Nutrition (HFS-200), Food and Drug Administration, 
    200 C St. SW., Washington DC 20204-0001, 202-418-3074.
    
    SUPPLEMENTARY INFORMATION:
    
    I. Background
    
        The Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 301 
    et seq.) provides for the approval of the use of food additives that 
    are shown to be safe for their intended use. Section 409 of the act (21 
    U.S.C. 348) provides for the filing of petitions to request such 
    approval, and also authorizes FDA (by delegation) to initiate the 
    approval process. The agency receives food additive petitions for a 
    broad range of proposed uses, including petitions proposing the 
    approval of a substance for use in reducing the number of pathogens in 
    or on food.
        FDA believes it is in the interest of enhanced food safety to 
    review petitions for certain food additives in an expedited manner. 
    Expedited review will generally be considered when an additive is 
    intended to decrease the incidence of foodborne illness through its 
    antimicrobial action against human pathogens that might be present in 
    food.
    
    [[Page 518]]
    
        Designating a food additive petition for expedited review means 
    that the food additive petition would be reviewed ahead of other 
    pending food additive petitions, i.e., the petition will be placed at 
    the beginning of the appropriate review queues. All other aspects of 
    the review process (e.g., data requirements for the petition, 
    procedures for evaluating petitions and communicating with petitioners) 
    will be the same for an expedited review petition as for all other food 
    additive petitions.
    
    II. Significance of Guidance
    
        This guidance document represents the agency's current thinking on 
    the procedures to be followed for expedited review of food additive 
    petitions. It does not create or confer any rights for or on any person 
    and does not operate to bind FDA or the public. An alternative approach 
    may be used if such approach satisfies the requirements of the 
    applicable statute, regulations, or both.
        The guidance document entitled ``Food Additive Petition Expedited 
    Review--Guidance for Industry and Center for Food Safety and Applied 
    Nutrition Staff'' is a Level 1 guidance under the agency's Good 
    Guidance Practices (62 FR 8961, February 27, 1997). Level 1 guidance 
    documents are generally subject to public comment prior to 
    implementation. However, public comment prior to implementation of this 
    guidance document is not required because there is a public health 
    justification for immediate implementation.
    
    III. Comments
    
        Interested persons may, at any time, submit to the Dockets 
    Management Branch (address above) written comments regarding the 
    guidance document. Two copies of any comments are to be submitted, 
    except that individuals may submit one copy. Comments are to be 
    identified with the docket number found in brackets in the heading of 
    this document. The guidance document and received comments may be seen 
    in the office above between 9 a.m. and 4 p.m., Monday through Friday. 
    Such comments will be considered when determining whether to amend the 
    guidance.
    
    IV. Electronic Access
    
        The guidance may also be accessed at the Center for Food Safety and 
    Applied Nutrition home page on the World Wide Web at ``http://
    www.fda.gov/cfsan''.
    
        Dated: December 15, 1998.
    William K. Hubbard,
    Associate Commissioner for Policy Coordination.
    [FR Doc. 99-70 Filed 1-4-99; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
01/05/1999
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
99-70
Dates:
Written comments concerning this guidance may be submitted at any time.
Pages:
517-518 (2 pages)
Docket Numbers:
Docket No. 98D-1164
PDF File:
99-70.pdf